Quarterly report pursuant to Section 13 or 15(d)

BUSINESS (Details Narrative)

v3.22.2.2
BUSINESS (Details Narrative)
Oct. 31, 2020
Jul. 28, 2016
Equity issued ownership Convertible share percentage   24.20%
Equity issued ownership percentage   75.80%
BioCorRx Pharmaceuticals, Inc [Member]    
Management fee 65.00%